Phaseline

Companies › Kyverna Therapeutics

Kyverna Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 3 registered trials: 2 Phase 2, 1 Phase 1; Neurology, Immunology; next expected readout Apr 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
KYV-101
anti-CD19 chimeric antigen receptor T-cell therapy
CD19Phase 2Multiple Sclerosis, Primary Progressive; Myasthenia Gravis; Idiopathic Inflammatory MyopathiesApr 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06152172KYV-101Phase 1Idiopathic Inflammatory MyopathiesImmunologyFeb 2027
NCT06384976KYV-101Phase 2Multiple Sclerosis, Primary ProgressiveNeurologyApr 2027
NCT06193889KYV-101Phase 2Myasthenia GravisNeurologySep 2027

From the company's SEC filings

Cash and short-term investments of $199m on 2026-06-30; operating cash outflow about $166m a year; runway about 14 months at that burn, to Sep 2027; 1 of 2 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 4 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

CD19 (1)

Companies with the same targets

Gilead Sciences Bristol-Myers Squibb Chongqing Precision Biotech Allogene Therapeutics Miltenyi Biomedicine Amgen AstraZeneca Beijing Yongtai Ruike Biotechnology Company Shanghai Ming Ju Biotechnology iCell Gene Therapeutics

Companies built like this

Autolus Cabaletta Bio Hope Biosciences Research Foundation Shanghai Ming Ju Biotechnology Fate Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.